SKI Market

A+| A| A-|

Indian Indices

Sensex

74,550.70 -225.04
( -0.30%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

67,130.34 800.84
(1.21%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4615746

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

37.07

11154.63

EPS(TTM)

Face Value()

Div & Yield %

6.64

Back

ITI reports consolidated net loss of Rs 25.33 crore in the December 2025 quarter

Feb 13,2026

Net Loss of ITI reported to Rs 25.33 crore in the quarter ended December 2025 as against net loss of Rs 48.88 crore during the previous quarter ended December 2024. Sales declined 50.25% to Rs 514.65 crore in the quarter ended December 2025 as against Rs 1034.54 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	514.65	1034.54	-50
OPM %	4.92	-1.02	-
PBDT	-9.74	-36.21	73
PBT	-20.75	-48.88	58
NP	-25.33	-48.88	48

74,550.70 -225.04 ( -0.30%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

67,130.34 800.84 (1.21%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)